I-MAB BIOPHARMA Trademark

Trademark Overview


On Tuesday, July 16, 2019, a trademark application was filed for I-MAB BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the I-MAB BIOPHARMA trademark a serial number of 88517411. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by I-MAB. The I-MAB BIOPHARMA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies

Biomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies
i-mab biopharma

General Information


Serial Number88517411
Word MarkI-MAB BIOPHARMA
Filing DateTuesday, July 16, 2019
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6629613
Registration DateTuesday, January 25, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements


Description of MarkThe mark consists of a blue and green stylized ring having a blue and dark blue left portion and a green and light green right portion. To the right of the ring is the word "I-MAB" written in dark blue upper case letters with a fading green arched cross-stroke extending from the left leg of the letter "A" through its center and extending through the center of the letter "B". Below the word "I-MAB" is the word "BIOPHARMA" written in dark blue upper case letters. The color white appearing in the mark represents transparent space and is not a part of the mark.
Goods and ServicesMonoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies
Indication of Colors claimedThe color(s) blue, dark blue, green, and light green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOPHARMA"
Goods and ServicesBiomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 23, 2019
Primary Code005
First Use Anywhere DateMonday, April 13, 2020
First Use In Commerce DateTuesday, April 28, 2020

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 23, 2019
Primary Code042
First Use Anywhere DateMonday, April 13, 2020
First Use In Commerce DateTuesday, April 28, 2020

Trademark Owner History


Party NameI-MAB BIOPHARMA CO., LTD
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSHANGHAI 201210
CN

Party NameI-MAB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGeorge Town KY1-1205
KY

Party NameI-MAB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGeorge Town KY1-1205
KY

Party NameI-MAB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGeorge Town KY1-1205
KY

Trademark Events


Event DateEvent Description
Wednesday, May 17, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Friday, December 24, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 23, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 23, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, December 23, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 23, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, December 23, 2021SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, December 21, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, November 12, 2021USE AMENDMENT FILED
Monday, December 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 12, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, November 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 2, 2021ASSIGNED TO LIE
Monday, August 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 1, 2021NON-FINAL ACTION E-MAILED
Thursday, July 1, 2021NON-FINAL ACTION WRITTEN
Friday, June 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 3, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, April 13, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 13, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, April 9, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 9, 2020LETTER OF SUSPENSION E-MAILED
Thursday, April 9, 2020SUSPENSION LETTER WRITTEN
Wednesday, March 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 24, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 24, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019NON-FINAL ACTION E-MAILED
Thursday, September 12, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 10, 2019ASSIGNED TO EXAMINER
Wednesday, July 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 19, 2019NEW APPLICATION ENTERED